Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] | ||
Ligand | BDBM577145 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Scintillation Proximity Assay | ||
IC50 | 2.99±n/a nM | ||
Citation | Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Chandrasekaran, RY Tricyclic compounds and their use as phosphodiesterase inhibitors US Patent US11472805 Publication Date 10/18/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] | |||
Name: | cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] | ||
Synonyms: | DPDE2 | PDE4A | PDE4A_HUMAN | cAMP-specific 3',5'-cyclic phosphodiesterase (PDE4A3) (2-825) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 92170.87 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 2-825 | ||
Residue: | 824 | ||
Sequence: |
| ||
BDBM577145 | |||
n/a | |||
Name | BDBM577145 | ||
Synonyms: | 4-(8-Cyclopropyl-9-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]pyrrolo[1,2-a]pyrazin-10-yl)-3-methylbenzonitrile | US11472805, Example 50 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H18N4O | ||
Mol. Mass. | 342.3938 | ||
SMILES | Cc1cc(ccc1-c1c2C(=O)N(CCn2c2cccnc12)C1CC1)C#N |(-3,.66,;-1.5,.98,;-1.02,2.44,;.5,2.81,;1.51,1.62,;1.04,.15,;-.47,-.17,;-.94,-1.63,;-.04,-2.88,;1.49,-3.04,;2.4,-1.79,;2.12,-4.45,;1.21,-5.69,;-.32,-5.53,;-.94,-4.12,;-2.41,-3.65,;-3.74,-4.42,;-5.08,-3.65,;-5.08,-2.11,;-3.74,-1.34,;-2.41,-2.11,;3.65,-4.61,;4.87,-5.55,;5.08,-4.02,;.98,4.28,;1.45,5.74,)| | ||
Structure |